+44 (0)1865-842-976 (UK)

+91 20 30108 270 (ASIA)

Cellular therapies hold the potential to revolutionize health care for a variety of diseases. However, the limitations lie in the productivity of engineered cells and the safe, efficacious and cost effective transformation of commercialized cell therapies. The industry is yet to address certain gaps relating to these limitations that will facilitate clinical and commercial success of these therapies. The aim of the conference is to assess the risks and benefits of the cell culture and cell therapy bio-manufacturing by focusing in particular on the feasibility of process automation: its impact on regulatory compliance and return on investment.

MarketsandMarkets has put together a unique platform to establish the reproducible and robust manufacturing processes for the production of stable cell culture and therapeutic cells. At the Cell Culture & Cell Therapy: Bioprocessing Conference scheduled to be held in Philadelphia, USA on 26 - 27 June 2017, leading experts in the industry will be gathered to discuss strategies, technologies and innovations in the area of bioprocessing of cell culture and cell-gene therapies.

conference Registration Form

-




 
  

CategoryCost
Academic Delegate$399
Industry Delegate $599
Academic Delegate (Early Bird) - 31st March 2017$299
Solution Provider Delegate$999
Industry Delegate (Early Bird) - 31st March 2017$499

Agenda

Key Highlights

  • Fermentation technologies
  • Device technologies for bioprocessing of cell culture
  • Next generation cellular models
  • Optimization of cell culture process
  • Closed system manufacturing of cells
  • Process development for next generation bio-therapeutics
  • Ex-vivo gene therapy application
  • Compatibility and stability of cell therapy products
  • Automation process development and control
  • C-GMP compliance guidelines
  • FDA approvals and regulatory policies
  • Commercialized view of bioprocessing
  • Insurance and reinvestment policies

Who Should Attend ?

From Pharmaceuticals, biopharmaceuticals and therapeutics based companies:

Engineers/Scientists/Researchers/Project leaders/VPs/Heads in:

  • Bioprocess development
  • Cellular Therapy
  • Gene Therapy
  • Therapeutics
  • Pharmacology
  • Quality Control
  • Biotherapeutics
  • Cell Engineering
  • Regulatory affairs

 

From Universities and Research Institutes:

Scientists/Professors/Researchers/Project leaders in

  • Bioprocessing
  • Biochemistry
  • Bioengineering
  • Biomaterials
  • Chemical Engineering
  • Molecular Biology
  • Material Sciences
  • Pharmacology
  • Biotechnology
  • Cell therapy
  • Gene therapy
  • Cell culture
  • Cell Engineering

Advisory Panel

  • Dr. J Joseph Melenhorst
    Director, Product Development & Correlative Sciences laboratories
    Penn Medicine, University of Pennsylvania
  • Dr. Scott R. Burger
    Principal 
    Advanced Cell & Gene Therapy, LLC
  • Dr. Benjamin Fryer
    Team Leader, CMC, Cardiomyocyte Cell Manufacturing
    University of Washington
     

     

SPEAKERS

  • Dr. Robert Nerem

    Institute Professor Emeritus, Georgia Institute of Technology
  • Dr. Robert Dream

    Managing Director, HDR Company LLC
  • Dr. Scott R. Burger

    Principal, Advanced Cell & Gene Therapy, LLC
  • Dr. Timothy Laden

    Director, Tissue and Cellular Innovation Center Biology Department, University of Wisconsin-River Falls
  • J Joseph Melenhorst

    Director, Product Development & Correlative Sciences laboratories, Penn Medicine, University of Pennsylvania
  • Dr. Benjamin Fryer

    Team Leader, CMC, Cardiomyocyte Cell Manufacturing, University of Washington
  • Dr. Juliana Woda

    Project Manager, BioMotiv
  • Dr. Qasim Rafiq

    Assistant Professor, Aston University
  • Dr. Chris Albanese

    Director, Preclinical Imaging Research Laboratory (PIRL), Georgetown University Medical Center
  • Dr. John M. Baust

    President and CEO, CPSI Biotech
  • Dr. Tiffany D Rau

    Head of Technical Operations, Evonik
  • Dr. Aby J. Mathew

    Sr. Vice President & Chief Technology Officer, BioLife Solutions
  • Dr. Andrew D Fesnak

    Assistant Professor of Clinical Pathology and Laboratory Medicine, University of Pennsylvania
  • Dr. Ravinder Bhatia

    Scientific Director, Johnson & Johnson
  • Dr. Knut Niss

    Asset Leader Cell Therapies- Director PO&T, Biogen
  • Dr. Govindarajan Dhanasekaran

    Lead-Virology (Upstream process development), Merck
  • Dr. Dawn Maier

    Associate Director-Cellular Process Development, Bluebird Bio
  • Biren Mistry

    Senior Engineer-Bioprocess Development, Celgene
  • Jamal Meghrous

    Cell culture specialist, Protein Sciences, Inc.
  • David Schaffer

    Professor, Chemical and Biomolecular Engineering, University of California at Berkeley
  • Dr. Joseph J. Pancrazio

    Associate Provost-Professor, Department of Bioengineering, The University of Texas at Dallas
  • Dr. Jeffrey Bartlett

    Chief Scientific Officer, Calimmune Inc.
  • Dr. Jonathan M. Shillingford

    Associate Director-Cell Biology, Endocyte Inc
  • Susan Celia Roberts

    Professor, Chemical Engineering, Worcester Polytechnic Institute, Massachusetts
  • Adrian P. Gee

    Professor of Medicine & Pediatrics, Center for Cell & Gene Therapy, Baylor College of Medicine, Texas
  • Dr. Adam Elhofy

    Chief Scientific Officer, Essential Pharmaceuticals LLC.
  • Hooman Hefzi

    Research Fellow
  • Dr. Michael Chorny

    Associate Director, Center for Targeted Therapeutics & Translational Nanomedicine
  • Dr. Arvind Natarajan

    Global CMC Lead, Novartis
  • Dr. Fang Tian

    Lead Scientist, Cell Biology group leader, ATCC
  • Dr. Biju Parrekadan

    Associate Professor, Biomedical Engineering and Medicine, Rutgers University
    

SPONSORS


Gold Sponsor

Essential PharmaceuticalsEssential Pharmaceuticals

Essential Pharmaceuticals  offers Cell-Ess.  Added to any CHO media in large scale bioproduction, it boosts protein yield >25%, increases cell productivity and maintains consistent glycosylation profiles. Manufactured under cGMP. Device master file available.  100% synthetic, chemically defined, low lot-to-lot variation, animal component free. Let Cell-Ess bring control to your process.




MarketsandMarkets provides a variety of direct and indirect marketing and networking opportunities for sponsors and exhibitors. 

Exhibiting
All refreshment breaks and lunches take place in the main exhibition ensuring that exhibitors enjoy maximum time to meet and network with senior level attendees. 

Speaking and Workshop Opportunities

  • 15 minute small company showcase presentations.
  • 30 minute presentations on the main conference programme.
  • 25 minute satellite symposiums.
  • 60 minute presentation / workshop on the main conference programme.

Please enquire for pre and post events workshop options. 

Pre-arranged One-on-Meetings
Prearranged one-on-one meetings ensure that you have personal time with your choice of delegates. Twenty minute meetings take place during refreshment breaks. Full delegate profiles are provided prior to the conference to ensure that onsite, you meet with relevant delegates who are truly interested in your products and services. Meetings can take place on your exhibition or in your own private meeting area. 

Pre-event Support
MnM Conferences provide full service pre-event marketing and branding support. Opportunities available include: 

  • Your logo and company description on the event website.
  • Your logo on all marketing materials as a sponsor.
  • Pre-event email shots to attending delegates to increase your onsite exposure.
  • Articles about your products and services in our monthly event newsletter.

For sponsorship opportunities please contact Ajay Nimbalkar at ajay.nimbalkar@marketsandmarkets.com

SUPPORTING ASSOCIATIONS

BioPharma Research CouncilBioPharma Research Council

The BioPharma Research Council is a nonprofit association for scientists, IT experts, entrepreneurs, and business professionals across all the many silos of biomedical research. Our mission is to foster collaboration and communication among professionals in industry, academia, nonprofit, government, and supplier labs in the biotech/biopharma space. Through conferences, symposia, webinars, Meetups, and committees, the BRC offers engaging in educational content to its community of more than 10,000 scientists, researchers, engineers, and industry experts each year. Many of these programs were suggested and developed through the energy and expertise of members of our community. Have an idea? Be in touch! info@biopharmaresearchcouncil.org



The United Kingdom Society for Biomaterials (UKSB)United Kingdom Society for Biomaterials (UKSB)

The United Kingdom Society for Biomaterials (UKSB) was set up to serve the diverse, interdisciplinary biomaterials research community. This was in response to the findings of a joint working party of the Institute of Materials and the Institute of Physics & Engineering in Medicine. The UKSB is the democratic Society for the whole biomaterials community.


Global Institute of Stem Cell Therapy and Research (GIOSTAR)Global Institute of Stem Cell Therapy and Research (GIOSTAR)

GIOSTAR is a coalition of esteemed and illustrious scientific minds in the field of stem cell science, genetics and cancer research. GIOSTAR Chairman Dr. Anand Srivastva is credited for starting and establishing the field of stem cell science at the top universities of U.S.A. For over 15 years, GIOSTAR team of scientists and clinicians have been involved in the development and utilization of stem cell based clinical protocols related to stem cell transplants.
BIOTECH RESEARCH SOCIETY OF INDIABiotech Research Society, India

Biotech Research Society, India is a non-profit, scientific, professional society dedicated to promote excellence and competence in the field of biotechnology for the benefit of mankind.




Irish Stem Cell FoundationIrish Stem Cell Foundation

The Irish Stem Cell Foundation is an independent, non-profit medical research charity. Established in October 2009, it is composed of researchers, clinicians, patients advocates, patients, science communicators, bioethicists, lawyers, teachers, and students.


Swiss Biotech Association

Swiss Biotech Association (SBA) 

Swiss Biotech Association (SBA) was founded in March 1998. Today over 210 companies are member of the growing national industry association. SBA is the industry association for small and medium-sized enterprises that are active in all areas of biotechnology. It is also a highly resprected networking platform for multinational companies active in the sector. Activities of member companies span different sectors of biotechnology including (bio-) pharmaceuticals, diagnostics, agriculture, food, environmental biotechnology, nanotech, nutrition, cosmetics, marine-oriented research and specialty chemicals.  The SBA partners with the Swiss life science clusters and manages Swiss Biotech™ - the global brand for the industry.  

Since 2013, the academic network “biotechnet Switzerland” and the industry network “Swiss Biotech Association” together manage the “National Thematic Network (NTN) Swiss Biotech™” sponsored by the Swiss Commission for Technology & Innovation (CTI). NTN Swiss Biotech™ is a well-functioning network in Switzerland bringing together research institutions and industrial partners in life sciences. The network and its members are committed to collaborating with the CTI and its unique support services.


RegMedNetRegMedNet

RegMedNet
 is a free online information and networking hub covering all aspects of the multidisciplinary field of regenerative medicine. By allowing members to quickly access user-generated news, discussion and opinion from the fast-moving and diverse field, share their own content and insights, and access key journal articles, RegMedNet enables the knowledge sharing, connection and collaboration that will help this exciting field progress further and bring benefits to patients faster.


To support Cell Culture & Cell Therapy: Bioprocessing Conference, please contact Ajay Nimbalkar t ajay.nimbalkar@marketsandmarkets.com


Swiss Biotech Association (SBA) 

Swiss Biotech Association (SBA) was founded in March 1998. Today over 210 companies are member of the growing national industry association. SBA is the industry association for small and medium-sized enterprises that are active in all areas of biotechnology. It is also a highly resprected networking platform for multinational companies active in the sector. Activities of member companies span different sectors of biotechnology including (bio-) pharmaceuticals, diagnostics, agriculture, food, environmental biotechnology, nanotech, nutrition, cosmetics, marine-oriented research and specialty chemicals.  The SBA partners with the Swiss life science clusters and manages Swiss Biotech™ - the global brand for the industry.  

Since 2013, the academic network “biotechnet Switzerland” and the industry network “Swiss Biotech Association” together manage the “National Thematic Network (NTN) Swiss Biotech™” sponsored by the Swiss Commission for Technology & Innovation (CTI). NTN Swiss Biotech™ is a well-functioning network in Switzerland bringing together research institutions and industrial partners in life sciences. The network and its members are committed to collaborating with the CTI and its unique support services.

Swiss Biotech Association (SBA) 

Swiss Biotech Association (SBA) was founded in March 1998. Today over 210 companies are member of the growing national industry association. SBA is the industry association for small and medium-sized enterprises that are active in all areas of biotechnology. It is also a highly resprected networking platform for multinational companies active in the sector. Activities of member companies span different sectors of biotechnology including (bio-) pharmaceuticals, diagnostics, agriculture, food, environmental biotechnology, nanotech, nutrition, cosmetics, marine-oriented research and specialty chemicals.  The SBA partners with the Swiss life science clusters and manages Swiss Biotech™ - the global brand for the industry.  

Since 2013, the academic network “biotechnet Switzerland” and the industry network “Swiss Biotech Association” together manage the “National Thematic Network (NTN) Swiss Biotech™” sponsored by the Swiss Commission for Technology & Innovation (CTI). NTN Swiss Biotech™ is a well-functioning network in Switzerland bringing together research institutions and industrial partners in life sciences. The network and its members are committed to collaborating with the CTI and its unique support services.

Swiss Biotech Association (SBA) 

Swiss Biotech Association (SBA) was founded in March 1998. Today over 210 companies are member of the growing national industry association. SBA is the industry association for small and medium-sized enterprises that are active in all areas of biotechnology. It is also a highly resprected networking platform for multinational companies active in the sector. Activities of member companies span different sectors of biotechnology including (bio-) pharmaceuticals, diagnostics, agriculture, food, environmental biotechnology, nanotech, nutrition, cosmetics, marine-oriented research and specialty chemicals.  The SBA partners with the Swiss life science clusters and manages Swiss Biotech™ - the global brand for the industry.  

Since 2013, the academic network “biotechnet Switzerland” and the industry network “Swiss Biotech Association” together manage the “National Thematic Network (NTN) Swiss Biotech™” sponsored by the Swiss Commission for Technology & Innovation (CTI). NTN Swiss Biotech™ is a well-functioning network in Switzerland bringing together research institutions and industrial partners in life sciences. The network and its members are committed to collaborating with the CTI and its unique support services.

Venue

Venue

Cell Culture & Cell Therapy: Bioprocessing Conference will be held at the Radisson Hotel Philadelphia Northeast in Philadelphia, USA.

Radisson Hotel Philadelphia Northeast

2400 Old Lincoln Highway
Trevose, Pennsylvania 19053 US


Hotel Booking Link

Accommodation is currently available at the Radisson Hotel Philadelphia Northeast at discounted rate. You will receive a link to book your accommodation via once you are fully registered. (Please note that we do not authorize any 3rd party agencies (e.g. Exhibitors Housing Management) to book on our behalf and, occasionally, companies fraudulently try to represent us. If you are contacted by anyone other than us regarding your accommodation requirements for this event, please let us know immediately on events@marketsandmarkets.com).

About the Hotel

As an official hotel of Sesame Place theme park, Radisson Hotel Philadelphia Northeast is the perfect place for families to rest and recharge. Located near the intersection of US-1 and I-276, just 30 minutes from Historic Philadelphia, we provide easy access to nearby destinations like Philadelphia Mills mall. After a day of theme park thrills or non-stop shopping, grab a bite at our on-site restaurant and update social media with free Wi-Fi. You can also relax on the sundeck while the kids splash in our indoor/outdoor pool.

For further Information, please contact:
Email: events@marketsandmarkets.com